The angiopoietin-Tie2 signaling axis in the vascular leakage of systemic inflammation

Tissue Barriers

Volumn 3, Issue 1, 2015, Pages

  Milam, Katelyn E ^a   Parikh, Samir M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Angiopoietin; Anthrax; ARDS; Barrier function; Endothelium; Inflammation; Lung injury; Malaria; Respiratory distress; Sepsis; Tie1; Tie2; Vascular leakage; VE PTP

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; CADHERIN; CD18 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MICRORNA; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR B; PROTEIN TYROSINE PHOSPHATASE; RAC1 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; VASCULOTROPIN RECEPTOR 2;

ADULT RESPIRATORY DISTRESS SYNDROME; BLOOD VESSEL PARAMETERS; BLOOD VOLUME; ENDOTHELIUM; FLUORESCENCE RESONANCE ENERGY TRANSFER; FOCAL ADHESION; GAS EXCHANGE; HUMAN; INFLAMMATION; LEUKOCYTE ADHERENCE; LEUKOCYTE ADHESION DEFICIENCY; MYCOPLASMA PULMONIS; NONHUMAN; ORGAN INJURY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; VASCULAR LEAKAGE;

EID: 84942814326     PISSN: 21688362     EISSN: 21688370     Source Type: Journal    
DOI: 10.4161/21688362.2014.957508     Document Type: Review

References (84)

1. Partanen J, Armstrong E, Makela TP, Korhonen J, Sandberg M, Renkonen R, Knuutila S, Huebner K, Alitalo K. A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol Cell Biol 1992; 12:1698-707; PMID:1312667.
2. Dumont DJ, Yamaguchi TP, Conlon RA, Rossant J, Breitman ML. Tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. Oncogene 1992; 7:1471-80; PMID:1630810.
3. Dumont DJ, Gradwohl G, Fong GH, Puri MC, Gertsenstein M, Auerbach A, Breitman ML. Dominant- negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 1994; 8:1897-909; PMID:7958865; http://dx.doi.org/10.1101/gad.8.16.1897.
4. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, et al. Angiopoietin- 2, a natural antagonist for tie2 that disrupts in vivo angiogenesis. Science 1997; 277:55-60; PMID: 9204896; http://dx.doi.org/10.1126/science.277.5322.55.
5. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. Requisite role of angiopoietin-1, a ligand for the tie2 receptor, during embryonic angiogenesis. Cell 1996; 87:1171-80; PMID:8980224; http://dx.doi.org/10.1016/S0092-8674(00)81813-9.
6. Yuan HT, Venkatesha S, Chan B, Deutsch U, Mammoto T, Sukhatme VP, Woolf AS, Karumanchi SA. Activation of the orphan endothelial receptor tie1 modifies tie2-mediated intracellular signaling and cell survival. FASEB J 2007; 21:3171-83; PMID:17504972; http://dx.doi.org/10.1096/fj.07-8487com.
7. Seegar TC, Eller B, Tzvetkova-Robev D, Kolev MV, Henderson SC, Nikolov DB, Barton WA. Tie1-tie2 interactions mediate functional differences between angiopoietin ligands. Mol Cell 2010; 37:643-55; PMID:20227369; http://dx.doi.org/10.1016/j.molcel.2010.02.007.
8. Jeltsch M, Leppanen VM, Saharinen P, Alitalo K. Receptor tyrosine kinase-mediated angiogenesis. Cold Spring Harb Perspect Biol 2013; 5(9); PMID: 24003209;.
9. Jones N, Dumont DJ. The tek/tie2 receptor signals through a novel dok-related docking protein, dok-r. Oncogene 1998; 17:1097-108; PMID:9764820; http://dx.doi.org/10.1038/sj.onc.1202115.
10. Harfouche R, Hassessian HM, Guo Y, Faivre V, Srikant CB, Yancopoulos GD, Hussain SN. Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells. Microvasc Res. 2002; 64:135-147; PMID:12074640; http://dx.doi.org/10.1006/mvre.2002.2421.
11. Li X, Stankovic M, Bonder CS, Hahn CN, Parsons M, Pitson SM, Xia P, Proia RL, Vadas MA, Gamble JR. Basal and angiopoietin-1-mediated endothelial permeability is regulated by sphingosine kinase-1. Blood. 2008; 111:3489-97; PMID:18199826; http://dx.doi.org/10.1182/blood-2007-05-092148.
12. Mammoto T, Parikh SM, Mammoto A, Gallagher D, Chan B, Mostoslavsky G, Ingber DE, Sukhatme VP. Angiopoietin-1 requires p190 rhogap to protect against vascular leakage in vivo. J Biol Chem. 2007; 282:23910-8; PMID:17562701; http://dx.doi.org/10.1074/jbc.M702169200.
13. Ghosh CC, Mukherjee A, David S, Knaus UG, Stearns-Kurosawa DJ, Kurosawa S, Parikh SM. Impaired function of the tie-2 receptor contributes to vascular leakage and lethality in anthrax. Proc Natl Acad Sci U S A. 2012; 109:10024-9; PMID: 22665799; http://dx.doi.org/10.1073/pnas.1120755109.
14. Yuan HT, Khankin EV, Karumanchi SA, Parikh SM. Angiopoietin 2 is a partial agonist/antagonist of tie2 signaling in the endothelium. Mol Cell Biol 2009; 29:2011-22; PMID:19223473; http://dx.doi.org/10.1128/MCB.01472-08.
15. Bogdanovic E, Nguyen VP, Dumont DJ. Activation of tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization. J Cell Sci 2006; 119:3551-60; PMID:16895971; http://dx.doi.org/10.1242/jcs.03077.
16. Cascone I, Napione L, Maniero F, Serini G, Bussolino F. Stable interaction between alpha5beta1 integrin and tie2 tyrosine kinase receptor regulates endothelial cell response to ang-1. J Cell Biol 2005; 170:993-1004; PMID:16157706; http://dx.doi.org/10.1083/jcb.200507082.
17. Felcht M, Luck R, Schering A, Seidel P, Srivastava K, Hu J, Bartol A, Kienast Y, Vettel C, Loos EK, et al. Angiopoietin-2 differentially regulates angiogenesis through tie2 and integrin signaling. J Clin Invest 2012; 122:1991-2005; PMID:22585576; http://dx.doi.org/10.1172/JCI58832.
18. Gale NW, Thurston G, Hackett SF, Renard R, Wang Q, McClain J, Martin C, Witte C, Witte MH, Jackson D, et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-.1. Dev Cell 2002; 3:411-23; PMID: 12361603; http://dx.doi.org/10.1016/S1534-5807(02)00217-4.
19. Wong AL, Haroon ZA, Werner S, Dewhirst MW, Greenberg CS, Peters KG. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res 1997; 81:567-74; PMID:9314838; http://dx.doi.org/10.1161/01.RES.81.4.567.
20. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, Yancopoulos GD. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000; 6:460-3; PMID:10742156; http://dx.doi.org/10.1038/74725.
21. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, McDonald DM. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999; 286:2511-4; PMID: 10617467; http://dx.doi.org/10.1126/science.286.5449.2511.
22. Parikh SM, Mammoto T, Schultz A, Yuan HT, Christiani D, Karumanchi SA, Sukhatme VP. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006; 3:e46; PMID:16417407; http://dx.doi.org/10.1371/journal.pmed.0030046.
23. Bhandari V, Choo-Wing R, Lee CG, Zhu Z, Nedrelow JH, Chupp GL, Zhang X, Matthay MA, Ware LB, Homer RJ, et al. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med 2006; 12:1286-93; PMID:17086189; http://dx.doi.org/10.1038/nm1494.
24. Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G, Gale NW, Witzenrath M, Rosseau S, Suttorp N, et al. Angiopoietin-2 sensitizes endothelial cells to tnf-alpha and has a crucial role in the induction of inflammation. Nat Med 2006; 12:235-9; PMID:16462802; http://dx.doi.org/10.1038/nm1351.
25. Parikh SM. Dysregulation of the angiopoietin-tie-2 axis in sepsis and ards. Virulence 2013; 4:517-24; PMID:23652985; http://dx.doi.org/10.4161/viru. 24906.
26. Trejo J, Altschuler Y, Fu HW, Mostov KE, Coughlin SR. Protease-activated receptor-1 down-regulation: A mutant hela cell line suggests novel requirements for par1 phosphorylation and recruitment to clathrincoated pits. J Biol Chem 2000; 275:31255-65; PMID:10893235; http://dx.doi.org/10.1074/jbc.M003770200.
27. Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature 2014; 510:92-101; PMID:24899309; http://dx.doi.org/10.1038/nature13479.
28. Springer TA, Thompson WS, Miller LJ, Schmalstieg FC, Anderson DC. Inherited deficiency of the mac- 1, lfa-1, p150,95 glycoprotein family and its molecular basis. J Exp Med 1984; 160:1901-18; PMID:6096477; http://dx.doi.org/10.1084/jem.160.6.190129.
29. Malinin NL, Zhang L, Choi J, Ciocea A, Razorenova O, Ma YQ, Podrez EA, Tosi M, Lennon DP, Caplan AI, et al. A point mutation in kindlin3 ablates activation of three integrin subfamilies in humans. Nat Med 2009; 15:313-8; PMID:19234460; http://dx.doi.org/10.1038/nm.1917.
30. Majno G, Palade GE, Schoefl GI. Studies on inflammation. Ii. The site of action of histamine and serotonin along the vascular tree: A topographic study. J Biophys Biochem Cytol 1961; 11:607-26; PMID:14468625; http://dx.doi.org/10.1083/jcb.11.3.607.
31. Majno G, Palade GE. Studies on inflammation. Ii.The effect of histamine and serotonin on vascular permeability: An electron microscopic study. J Biophys Biochem Cytol 1961; 11:571-605; PMID:14468626; http://dx.doi.org/10.1083/jcb.11.3.571.
32. Vandenbroucke E, Mehta D, Minshall R, Malik AB. Regulation of endothelial junctional permeability. Ann N Y Acad Sci 2008; 1123:134-45; PMID:18375586; http://dx.doi.org/10.1196/annals.1420.016.
33. Dejana E, Orsenigo F, Molendini C, Baluk P, McDonald DM. Organization and signaling of endothelial cell-to-cell junctions in various regions of the blood and lymphatic vascular trees. Cell Tissue Res 2009; 335:17-25; PMID:18855014; http://dx.doi.org/10.1007/s00441-008-0694-5.
34. Corada M, Mariotti M, Thurston G, Smith K, Kunkel R, Brockhaus M, Lampugnani MG, Martin- Padura I, Stoppacciaro A, Ruco L, et al. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Natl Acad Sci U S A 1999; 96:9815-20; PMID:10449777; http://dx.doi.org/10.1073/pnas.96.17.9815.
35. Yano K, Liaw PC, Mullington JM, Shih SC, Okada H, Bodyak N, Kang PM, Toltl L, Belikoff B, Buras J, et al. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med 2006; 203:1447-58; PMID:16702604; http://dx.doi.org/10.1084/jem.20060375.
36. London NR, Zhu W, Bozza FA, Smith MC, Greif DM, Sorensen LK, Chen L, Kaminoh Y, Chan AC, Passi SF, et al. Targeting robo4-dependent slit signaling to survive the cytokine storm in sepsis and influenza. Sci Transl Med 2010; 2:23ra19; PMID:20375003.
37. Puneet P, Yap CT, Wong L, Lam Y, Koh DR, Moochhala S, Pfeilschifter J, Huwiler A, Melendez AJ. Sphk1 regulates proinflammatory responses associated with endotoxin and polymicrobial sepsis. Science 2010; 328:1290-4; PMID:20522778; http://dx.doi.org/10.1126/science.1188635.
38. Sanchez T, Estrada-Hernandez T, Paik JH, Wu MT, Venkataraman K, Brinkmann V, Claffey K, Hla T. Phosphorylation and action of the immunomodulator fty720 inhibits vascular endothelial cell growth factor-induced vascular permeability. J Biol Chem 2003; 278:47281-90; PMID: 12954648; http://dx.doi.org/10.1074/jbc.M306896200.
39. Witzenbichler B, Westermann D, Knueppel S, Schultheiss HP, Tschope C. Protective role of angiopoietin- 1 in endotoxic shock. Circulation 2005; 111:97-105; PMID:15611372; http://dx.doi.org/10.1161/01.CIR.0000151287.08202.8E.
40. David S, Ghosh CC, Mukherjee A, Parikh SM. Angiopoietin-1 requires iq domain gtpase-activating protein 1 to activate rac1 and promote endothelial barrier defense. Arterioscler Thromb Vasc Biol 2011; 31:2643-52; PMID:21885850; http://dx.doi.org/10.1161/ATVBAHA.111.233189.
41. Dallabrida SM, Ismail N, Oberle JR, Himes BE, Rupnick MA. Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins. Circ Res 2005; 96:e8-24; PMID:15692086; http://dx.doi.org/10.1161/01.RES.0000158285.57191.60.
42. Xu Y, Yu Q. Angiopoietin-1, unlike angiopoietin-2, is incorporated into the extracellular matrix via its linker peptide region. J Biol Chem 2001; 276:34990-8; PMID:11447223; http://dx.doi.org/10.1074/jbc.M103661200.
43. Lampugnani MG, Resnati M, Dejana E, Marchisio PC. The role of integrins in the maintenance of endothelial monolayer integrity. J Cell Biol 1991; 112:479-90; PMID:1899416; http://dx.doi.org/10.1083/jcb.112.3.479.
44. Tournaire R, Simon MP, le Noble F, Eichmann A, England P, Pouyssegur J. A short synthetic peptide inhibits signal transduction, migration and angiogenesis mediated by tie2 receptor. EMBO reports 2004; 5:262-7; PMID:14978510; http://dx.doi.org/10.1038/sj.embor.7400100.
45. David S, Ghosh CC, Kumpers P, Shushakova N, Van Slyke P, Khankin EV, Karumanchi SA, Dumont D, Parikh SM. Effects of a synthetic peg-ylated tie-2 agonist peptide on endotoxemic lung injury and mortality. Am J Physiol Lung Cell Mol Physiol 2011; 300:L851-62; PMID:21421750; http://dx.doi.org/10.1152/ajplung.00459.2010.
46. Kumpers P, Gueler F, David S, Van Slyke P, Dumont DJ, Park JK, Bockmeyer CL, Parikh SM, Pavenstadt H, Haller H, et al. The synthetic tie2 agonist peptide vasculotide protects against vascular leakage and reduces mortality in murine abdominal sepsis. Crit Care 2011; 15:R261; PMID:22040774; http://dx.doi.org/10.1186/cc10523.
47. Jeansson M, Gawlik A, Anderson G, Li C, Kerjaschki D, Henkelman M, Quaggin SE. Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J Clin Invest 2011; 121:2278-89; PMID:21606590; http://dx.doi.org/10.1172/JCI46322.
48. Saharinen P, Eklund L, Miettinen J, Wirkkala R, Anisimov A, Winderlich M, Nottebaum A, Vestweber D, Deutsch U, Koh GY, et al. Angiopoietins assemble distinct tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat Cell Biol 2008; 10:527-37; PMID:18425119; http://dx.doi.org/10.1038/ncb1715.
49. Fukuhara S, Sako K, Minami T, Noda K, Kim HZ, Kodama T, Shibuya M, Takakura N, Koh GY, Mochizuki N. Differential function of tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nat Cell Biol 2008; 10:513-26; PMID:18425120; http://dx.doi.org/10.1038/ncb1714.
50. Aslan A, Jongman RM, Moser J, Stegeman CA, van Goor H, Diepstra A, van den Heuvel MC, Heeringa P, Molema G, Zijlstra JG, et al. The renal angiopoietin/tie2 system in lethal human sepsis. Crit Care 2014; 18:423; PMID:24976393; http://dx.doi.org/10.1186/cc13806.
51. David S, Mukherjee A, Ghosh CC, Yano M, Khankin EV, Wenger JB, Karumanchi SA, Shapiro NI, Parikh SM. Angiopoietin-2 may contribute to multiple organ dysfunction and death in sepsis. Crit Care Med 2012; 40:3034-41; PMID:22890252; http://dx.doi.org/10.1097/CCM.0b013e31825fdc31.
52. Fiedler U, Scharpfenecker M, Koidl S, Hegen A, Grunow V, Schmidt JM, Kriz W, Thurston G, Augustin HG. The tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell weibel-palade bodies. Blood 2004; 103:4150-6; PMID:14976056; http://dx.doi.org/10.1182/blood-2003-10-3685.
53. Stiehl T, Thamm K, Kaufmann J, Schaeper U, Kirsch T, Haller H, Santel A, Ghosh CC, Parikh SM, David S. Lung-targeted rna-interference against angiopoietin- 2 ameliorates multi-organ dusfunction and death in sepsis. Crit Care Med 2014; (accepted); PMID:25083983.
54. Daly C, Wong V, Burova E, Wei Y, Zabski S, Griffiths J, Lai KM, Lin HC, Ioffe E, Yancopoulos GD, et al. Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor fkhr (foxo1). Genes Dev 2004; 18:1060-71; PMID:15132996; http://dx.doi.org/10.1101/gad.1189704.
55. David S, Kumpers P, van Slyke P, Parikh SM. Mending leaky blood vessels: The angiopoietin-tie2 pathway in sepsis. J Pharmacol Exp Ther 2013; 345:2-6; PMID:23378191; http://dx.doi.org/10.1124/jpet.112.201061.
56. van der Heijden M, Pickkers P, van Nieuw Amerongen GP, van Hinsbergh VW, Bouw MP, van der Hoeven JG, Groeneveld AB. Circulating angiopoietin- 2 levels in the course of septic shock: Relation with fluid balance, pulmonary dysfunction and mortality. Intensive Care Med 2009; 35:1567-74; PMID:19551369; http://dx.doi.org/10.1007/s00134-009-1560-y.
57. van der Heijden M, van Nieuw Amerongen GP, Koolwijk P, van Hinsbergh VW, Groeneveld AB. Angiopoietin-2, permeability oedema, occurrence and severity of ali/ards in septic and non-septic critically ill patients. Thorax 2008; 63:903-9; PMID:18559364; http://dx.doi.org/10.1136/thx.2007.087387.
58. Meyer NJ, Li M, Feng R, Bradfield J, Gallop R, Bellamy S, Fuchs BD, Lanken PN, Albelda SM, Rushefski M, et al. Angpt2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio. Am J Respir Crit Care Med 2011; 183:1344-53; PMID:21257790; http://dx.doi.org/10.1164/rccm.201005-0701OC.
59. Kim KT, Choi HH, Steinmetz MO, Maco B, Kammerer RA, Ahn SY, Kim HZ, Lee GM, Koh GY. Oligomerization and multimerization are critical for angiopoietin-1 to bind and phosphorylate tie2. J Biol Chem 2005; 280:20126-31; PMID:15769741; http://dx.doi.org/10.1074/jbc.M500292200.
60. Davis S, Papadopoulos N, Aldrich TH, Maisonpierre PC, Huang T, Kovac L, Xu A, Leidich R, Radziejewska E, Rafique A, et al. Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering. Nat Struct Biol 2003; 10:38-44; PMID:12469114; http://dx.doi.org/10.1038/nsb880.
61. Barton WA, Tzvetkova-Robev D, Miranda EP, Kolev MV, Rajashankar KR, Himanen JP, Nikolov DB. Crystal structures of the tie2 receptor ectodomain and the angiopoietin-2-tie2 complex. Nat Struc Mol Biol 2006; 13:524-32; PMID:16732286; http://dx.doi.org/10.1038/nsmb1101.
62. Yu X, Seegar TC, Dalton AC, Tzvetkova-Robev D, Goldgur Y, Rajashankar KR, Nikolov DB, Barton WA. Structural basis for angiopoietin-1-mediated signaling initiation. Proc Natl Acad Sci U S A 2013; 110:7205-10; PMID:23592718; http://dx.doi.org/10.1073/pnas.1216890110.
63. Fuxe J, Tabruyn S, Colton K, Zaid H, Adams A, Baluk P, Lashnits E, Morisada T, Le T, O’Brien S, et al. Pericyte requirement for anti-leak action of angiopoietin-1 and vascular remodeling in sustained inflammation. Am J Pathol 2011; 178:2897-909; PMID:21550017; http://dx.doi.org/10.1016/j.ajpath.2011.02.008.
64. Ziegler T, Horstkotte J, Schwab C, Pfetsch V, Weinmann K, Dietzel S, Rohwedder I, Hinkel R, Gross L, Lee S, et al. Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis. J Clin Invest 2013; epub ahead of print; PMID:23863629.
65. Woo KV, Qu X, Babaev VR, Linton MF, Guzman RJ, Fazio S, Baldwin HS. Tie1 attenuation reduces murine atherosclerosis in a dose-dependent and shear stress-specific manner. J Clin Invest 2011; 121:1624- 35; PMID:21383501; http://dx.doi.org/10.1172/JCI42040.
66. Korhonen J, Partanen J, Armstrong E, Vaahtokari A, Elenius K, Jalkanen M, Alitalo K. Enhanced expression of the tie receptor tyrosine kinase in endothelialcells during neovascularization. Blood 1992; 80:2548-55; PMID:1384789.
67. Kaipainen A, Vlaykova T, Hatva E, Bohling T, Jekunen A, Pyrhonen S, Alitalo K. Enhanced expression of the tie receptor tyrosine kinase mesenger rna in the vascular endothelium of metastatic melanomas. Cancer Res 1994; 54:6571-7; PMID:7987857.
68. Puri MC, Rossant J, Alitalo K, Bernstein A, Partanen J. The receptor tyrosine kinase tie is required for integrity and survival of vascular endothelial cells. EMBO J 1995; 14:5884-91; PMID:8846781.
69. D’Amico G, Korhonen EA, Anisimov A, Zarkada G, Holopainen T, Hagerling R, Kiefer F, Eklund L, Sormunen R, Elamaa H, et al. Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy. J Clin Invest 2014; 124:824-34; PMID:24430181; http://dx.doi.org/10.1172/JCI68897.
70. van Meurs M, Kurniati NF, Wulfert FM, Asgeirsdottir SA, de Graaf IA, Satchell SC, Mathieson PW, Jongman RM, Kumpers P, Zijlstra JG, et al. Shockinduced stress induces loss of microvascular endothelial tie2 in the kidney which is not associated with reduced glomerular barrier function. Am J Physiol Renal Physiol 2009; 297:F272-81; PMID:19515812; http://dx.doi.org/10.1152/ajprenal.00137.2009.
71. Suarez Y, Fernandez-Hernando C, Yu J, Gerber SA, Harrison KD, Pober JS, Iruela-Arispe ML, Merkenschlager M, Sessa WC. Dicer-dependent endothelial micrornas are necessary for postnatal angiogenesis. Proc Natl Acad Sci U S A 2008; 105:14082-7; PMID:18779589; http://dx.doi.org/10.1073/pnas.0804597105.
72. Li R, Zijlstra JG, Kamps JA, van Meurs M, Molema G. Abrupt reflow enhances cytokine induced proinflammatory activation of endothelial cells during simulated shock and resuscitation. Shock 2014; PMID:25051282.
73. Wehrle C, Van Slyke P, Dumont DJ. Angiopoietin- 1-induced ubiquitylation of tie2 by c-cbl is required for internalization and degradation. Biochem J 2009; 423:375-80; PMID:19689429; http://dx.doi.org/10.1042/BJ20091010.
74. Fachinger G, Deutsch U, Risau W. Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor tie-2. Oncogene 1999; 18:5948-53; PMID:10557082; http://dx.doi.org/10.1038/sj.onc.1202992.
75. Baumer S, Keller L, Holtmann A, Funke R, August B, Gamp A, Wolburg H, Wolburg-Buchholz K, Deutsch U, Vestweber D. Vascular endothelial cellspecific phosphotyrosine phosphatase (ve-ptp) activity is required for blood vessel development. Blood 2006; 107:4754-62; PMID:16514057; http://dx.doi.org/10.1182/blood-2006-01-0141.
76. Dominguez MG, Hughes VC, Pan L, Simmons M, Daly C, Anderson K, Noguera-Troise I, Murphy AJ, Valenzuela DM, Davis S, et al. Vascular endothelial tyrosine phosphatase (ve-ptp)-null mice undergo vasculogenesis but die embryonically because of defects in angiogenesis. Proc Natl Acad Sci U S A 2007; 104:3243-8; PMID:17360632; http://dx.doi.org/10.1073/pnas.0611510104.
77. Kuppers V, Vockel M, Nottebaum AF, Vestweber D. Phosphatases and kinases as regulators of the endothelial barrier function. Cell Tissue Res. 2014; 355:577-86; PMID:24566520; http://dx.doi.org/10.1007/s00441-014-1812-1.
78. Hayashi M, Majumdar A, Li X, Adler J, Sun Z, Vertuani S, Hellberg C, Mellberg S, Koch S, Dimberg A, et al. Ve-ptp regulates vegfr2 activity in stalk cells to establish endothelial cell polarity and lumen formation. Nat Commun 2013; 4:1672; PMID:23575676; http://dx.doi.org/10.1038/ncomms2683.
79. Nawroth R, Poell G, Ranft A, Kloep S, Samulowitz U, Fachinger G, Golding M, Shima DT, Deutsch U, Vestweber D. Ve-ptp and ve-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. EMBO J 2002; 21:4885-95; PMID:12234928; http://dx.doi.org/10.1093/emboj/cdf497.
80. Esser S, Lampugnani MG, Corada M, Dejana E, Risau W. Vascular endothelial growth factor induces ve-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci 1998; 111(Pt 13):1853-65; PMID:9625748.
81. Bentley K, Franco CA, Philippides A, Blanco R, Dierkes M, Gebala V, Stanchi F, Jones M, Aspalter IM, Cagna G, et al. The role of differential ve-cadherin dynamics in cell rearrangement during angiogenesis. Nat Cell Biol 2014; 16:309-21; PMID:24658686; http://dx.doi.org/10.1038/ncb2926.
82. Broermann A, Winderlich M, Block H, Frye M, Rossaint J, Zarbock A, Cagna G, Linnepe R, Schulte D, Nottebaum AF, et al. Dissociation of ve-ptp from vecadherin is required for leukocyte extravasation and for vegf-induced vascular permeability in vivo. J Exp Med 2011; 208:2393-401; PMID:22025303; http://dx.doi.org/10.1084/jem.20110525.
83. Winderlich M, Keller L, Cagna G, Broermann A, Kamenyeva O, Kiefer F, Deutsch U, Nottebaum AF, Vestweber D. Ve-ptp controls blood vessel development by balancing tie-2 activity. J Cell Biol 2009; 185:657-71; PMID:19451274; http://dx.doi.org/10.1083/jcb.200811159.
84. De Palma M, Naldini L. Angiopoietin-2 ties up macrophages in tumor angiogenesis. Clin Cancer Res 2011; 17:5226-32; PMID:21576085; http://dx.doi.org/10.1158/1078-0432.CCR-10-0171